Arab Board Oncology Clinical common mistakes
Arab Board Oncology Clinical · Understand the traps and how to avoid them.
When a stem asks which single next step is required to establish a diagnosis, the candidate selects the definitive treatment or the full staging workup (e.g., choosing mastectomy or a PET-CT) instead of the biopsy or cytology that the question is asking for.
Candidates read the disease name and immediately jump to the management algorithm they have memorized, skipping the phrase in the stem that specifies the question being asked (diagnosis vs. staging vs. treatment).
What to do instead
Before answering, underline the interrogative phrase in the stem and classify it as diagnosis, staging, treatment, or follow-up. Generate the answer only for that step, then check that the chosen option does not belong to a later step in the pathway.
The candidate assigns a tumour stage from the imaging description alone, without applying the correct edition of the AJCC/UICC TNM system, and misassigns T or N category when the stem gives precise measurements or nodal descriptors (e.g., matted nodes, supraclavicular nodes, or tumour size crossing a category boundary).
Staging categories are memorized as general impressions rather than as numeric thresholds and site-specific rules, and candidates do not check which TNM edition the stem is implicitly using.
What to do instead
For each major solid tumour, build a one-page table of the numeric size cut-offs for T, the nodal count or descriptor rules for N, and site-specific M definitions. Practise 10 stems per tumour where you must write the T, N, and M before looking at the options.
In questions about adjuvant or neoadjuvant therapy, the candidate recommends systemic treatment based on the histological diagnosis alone, ignoring the receptor status, biomarker, or risk stratification data provided in the stem, or recommends treatment when the stage does not warrant it.
Candidates anchor on the tumour type and a familiar regimen, and treat biomarker results in the stem as background detail rather than as decision drivers.
What to do instead
List the decision variables for each adjuvant scenario (stage, receptor or biomarker status, nodal status, margin status, performance status) and require the chosen option to be justified by every variable present. If the stem gives a negative biomarker result, actively rule out the option that depends on it.
The candidate confuses the mechanism or class of a targeted agent or immunotherapy with its indication, its characteristic toxicity, or its monitoring requirement, and selects an option that pairs the correct drug with the wrong adverse effect or the wrong predictive biomarker.
Pharmacology is studied as drug lists rather than as mechanism-to-toxicity-to-biomarker chains, so the associations are fragile under exam pressure.
What to do instead
Build a three-column table for each agent: molecular target or pathway, predictive biomarker or indication, and signature toxicity with its monitoring test. Test yourself by covering one column at a time, in both directions (drug to toxicity and toxicity to drug).
The candidate selects a radiation dose, fractionation schedule, or volume concept without matching it to the intent of treatment (definitive, adjuvant, palliative, or emergency), and mixes up concepts such as conventional fractionation, hypofractionation, stereotactic ablative radiotherapy, and whole-brain versus focal cranial irradiation.
Radiation oncology is often the least clinically exposed domain during training, so doses and fractionation schemes are recalled as isolated numbers without the intent framework that determines them.
What to do instead
Organize radiotherapy facts by intent first, then by site. For each site, record the standard definitive dose and fractionation, the standard palliative regimen, and the normal-tissue constraint that most often appears in questions. Review the radiobiology of fractionation size and alpha/beta reasoning alongside the clinical schemes.
In haematology stems, the candidate chooses a treatment or a diagnostic test without first classifying the disease by its defining molecular or immunophenotypic marker, and mixes up entities that share a clinical presentation (e.g., different types of lymphoma or different genetic subtypes of leukaemia).
Haematologic malignancies are taught as overlapping clinical pictures, and the candidate relies on pattern recognition of symptoms rather than on the defining marker that the stem deliberately provides.
What to do instead
For each haematologic entity, write the single defining diagnostic feature (translocation, surface marker, or mutation), the prognostic factor that drives treatment intensity, and the standard first-line regimen. In practice stems, identify the defining feature before reading the options.
The candidate answers an oncologic emergency question with the diagnostic test or the definitive long-term treatment rather than the immediate stabilizing intervention, and fails to recognize the emergency when it is embedded in a stem describing a stable-looking patient with a subtle metabolic or haematologic abnormality.
Emergencies are studied as lists of syndromes rather than as time-critical action sequences, and the candidate does not rehearse the first 60 minutes of each emergency.
What to do instead
For each emergency (febrile neutropenia, tumour lysis syndrome, spinal cord compression, superior vena cava obstruction, hypercalcaemia, malignant pericardial tamponade), write the immediate action, the confirmatory test only if the patient is stable, and the definitive treatment. Practise recognizing each from its earliest laboratory or clinical clue.
The candidate confuses supportive care indications with treatment indications, for example choosing a growth factor, an antiemetic regimen, or a bone-modifying agent at the wrong prophylaxis timing, for the wrong emetogenic risk level, or in a patient for whom it is not indicated.
Supportive care is treated as low-yield background knowledge, so the specific risk stratification scales and timing rules are not learned precisely.
What to do instead
Memorize the emetogenicity classification of common regimens and the corresponding guideline-based antiemetic combination, the criteria for primary versus secondary growth factor prophylaxis, and the dosing interval and monitoring for bone-modifying agents. Anchor each fact to a risk category rather than to a drug name.
In biostatistics and research methodology questions, the candidate interprets a p-value as the probability that the null hypothesis is true or as a measure of effect size, and misreads confidence intervals, hazard ratios, or the results of intention-to-treat versus per-protocol analyses.
Statistical concepts are learned as formulas without the interpretive reasoning, and candidates answer from the number in the stem rather than from the definition of the measure being asked about.
What to do instead
Write plain-language definitions for p-value, confidence interval, hazard ratio, absolute versus relative risk reduction, number needed to treat, sensitivity, specificity, and predictive value, and apply them to published-style abstracts. For each abstract, state the primary endpoint, the analysis population, and whether the reported difference is statistically and clinically significant.
The candidate answers multidisciplinary management questions by choosing the single modality they associate most strongly with the tumour, instead of the sequence or combination that the evidence and the multidisciplinary team would recommend, and ignores the patient factors in the stem such as performance status, comorbidity, or patient preference.
Modalities are studied in separate silos, so the candidate lacks an integrated sequence map for each stage and defaults to the most familiar or most aggressive option.
What to do instead
For each major solid tumour and stage, draw a decision tree that shows the recommended sequence of surgery, systemic therapy, and radiotherapy, with the branch points defined by stage and patient fitness. When answering, first locate the stage and fitness branch in the stem, then select the option that matches that branch rather than the most familiar modality.